已收盘 12-12 16:00:00 美东时间
-0.380
-2.64%
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从12美元升至13美元;Guggenheim:维持Praxis Precision Medicine"买入"评级,目标价从540美元升至760美元
12-10 10:33
Roth Capital analyst Nick Pope maintains Infinity Natural (NYSE:INR) with a Buy and raises the price target from $17 to $18.
12-10 01:46
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从12美元升至15美元;Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至107美元
11-13 09:58
Keybanc analyst Tim Rezvan maintains Infinity Natural (NYSE:INR) with a Overweight and lowers the price target from $22 to $19.
11-12 21:38
Infinity Natural (NYSE:INR) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.43 by 51.16 percent. This is a 244.44 percent increase over losses of $(0.45) per share from the
11-11 05:08
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
Thermo Fisher Scientific: Expands Bengaluru R&D Facility, Investing INR 160...
10-28 01:13
Sify Technologies press release (NASDAQ:SIFY): Q2 EBITDA was INR 2361 Million, an increase of 20% over the same quarter last year. Loss before tax was INR 194 Million. Loss after tax was INR 275 Milli...
10-27 14:11
Redington Limited ( ($IN:REDINGTON) ) has shared an update. Redington Limited h...
10-26 14:52
An update from SRG Housing Finance Ltd. ( ($IN:SRGHFL) ) is now available. SRG ...
10-25 13:54